List of Tables
Table 1. Global Post Menopausal Osteoporosis Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Oral
Table 3. Key Players of Subcutaneous
Table 4. Key Players of Intravenous Injection
Table 5. Key Players of Others
Table 6. Global Post Menopausal Osteoporosis Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Post Menopausal Osteoporosis Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Post Menopausal Osteoporosis Drug Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Post Menopausal Osteoporosis Drug Market Share by Region (2019-2024)
Table 10. Global Post Menopausal Osteoporosis Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Post Menopausal Osteoporosis Drug Market Share by Region (2025-2030)
Table 12. Post Menopausal Osteoporosis Drug Market Trends
Table 13. Post Menopausal Osteoporosis Drug Market Drivers
Table 14. Post Menopausal Osteoporosis Drug Market Challenges
Table 15. Post Menopausal Osteoporosis Drug Market Restraints
Table 16. Global Post Menopausal Osteoporosis Drug Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Post Menopausal Osteoporosis Drug Market Share by Players (2019-2024)
Table 18. Global Top Post Menopausal Osteoporosis Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post Menopausal Osteoporosis Drug as of 2023)
Table 19. Ranking of Global Top Post Menopausal Osteoporosis Drug Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Post Menopausal Osteoporosis Drug Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Post Menopausal Osteoporosis Drug Product Solution and Service
Table 23. Date of Enter into Post Menopausal Osteoporosis Drug Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Post Menopausal Osteoporosis Drug Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Post Menopausal Osteoporosis Drug Revenue Market Share by Type (2019-2024)
Table 27. Global Post Menopausal Osteoporosis Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Post Menopausal Osteoporosis Drug Revenue Market Share by Type (2025-2030)
Table 29. Global Post Menopausal Osteoporosis Drug Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Post Menopausal Osteoporosis Drug Revenue Market Share by Application (2019-2024)
Table 31. Global Post Menopausal Osteoporosis Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Post Menopausal Osteoporosis Drug Revenue Market Share by Application (2025-2030)
Table 33. North America Post Menopausal Osteoporosis Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Post Menopausal Osteoporosis Drug Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Post Menopausal Osteoporosis Drug Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Post Menopausal Osteoporosis Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Post Menopausal Osteoporosis Drug Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Post Menopausal Osteoporosis Drug Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Post Menopausal Osteoporosis Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Post Menopausal Osteoporosis Drug Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Post Menopausal Osteoporosis Drug Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Post Menopausal Osteoporosis Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Post Menopausal Osteoporosis Drug Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Post Menopausal Osteoporosis Drug Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Post Menopausal Osteoporosis Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Post Menopausal Osteoporosis Drug Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Post Menopausal Osteoporosis Drug Market Size by Country (2025-2030) & (US$ Million)
Table 48. Amgen Inc Company Detail
Table 49. Amgen Inc Business Overview
Table 50. Amgen Inc Post Menopausal Osteoporosis Drug Product
Table 51. Amgen Inc Revenue in Post Menopausal Osteoporosis Drug Business (2019-2024) & (US$ Million)
Table 52. Amgen Inc Recent Development
Table 53. Ipsen SA Company Detail
Table 54. Ipsen SA Business Overview
Table 55. Ipsen SA Post Menopausal Osteoporosis Drug Product
Table 56. Ipsen SA Revenue in Post Menopausal Osteoporosis Drug Business (2019-2024) & (US$ Million)
Table 57. Ipsen SA Recent Development
Table 58. Aryogen Pharmed Co Company Detail
Table 59. Aryogen Pharmed Co Business Overview
Table 60. Aryogen Pharmed Co Post Menopausal Osteoporosis Drug Product
Table 61. Aryogen Pharmed Co Revenue in Post Menopausal Osteoporosis Drug Business (2019-2024) & (US$ Million)
Table 62. Aryogen Pharmed Co Recent Development
Table 63. Lupin Ltd Company Detail
Table 64. Lupin Ltd Business Overview
Table 65. Lupin Ltd Post Menopausal Osteoporosis Drug Product
Table 66. Lupin Ltd Revenue in Post Menopausal Osteoporosis Drug Business (2019-2024) & (US$ Million)
Table 67. Lupin Ltd Recent Development
Table 68. Celltrion Inc Company Detail
Table 69. Celltrion Inc Business Overview
Table 70. Celltrion Inc Post Menopausal Osteoporosis Drug Product
Table 71. Celltrion Inc Revenue in Post Menopausal Osteoporosis Drug Business (2019-2024) & (US$ Million)
Table 72. Celltrion Inc Recent Development
Table 73. Clayton Biotechnologies Inc Company Detail
Table 74. Clayton Biotechnologies Inc Business Overview
Table 75. Clayton Biotechnologies Inc Post Menopausal Osteoporosis Drug Product
Table 76. Clayton Biotechnologies Inc Revenue in Post Menopausal Osteoporosis Drug Business (2019-2024) & (US$ Million)
Table 77. Clayton Biotechnologies Inc Recent Development
Table 78. Hualan Biological Engineering Inc Company Detail
Table 79. Hualan Biological Engineering Inc Business Overview
Table 80. Hualan Biological Engineering Inc Post Menopausal Osteoporosis Drug Product
Table 81. Hualan Biological Engineering Inc Revenue in Post Menopausal Osteoporosis Drug Business (2019-2024) & (US$ Million)
Table 82. Hualan Biological Engineering Inc Recent Development
Table 83. Fresenius Kabi SwissBioSim GmbH Company Detail
Table 84. Fresenius Kabi SwissBioSim GmbH Business Overview
Table 85. Fresenius Kabi SwissBioSim GmbH Post Menopausal Osteoporosis Drug Product
Table 86. Fresenius Kabi SwissBioSim GmbH Revenue in Post Menopausal Osteoporosis Drug Business (2019-2024) & (US$ Million)
Table 87. Fresenius Kabi SwissBioSim GmbH Recent Development
Table 88. Genor BioPharma Co Ltd Company Detail
Table 89. Genor BioPharma Co Ltd Business Overview
Table 90. Genor BioPharma Co Ltd Post Menopausal Osteoporosis Drug Product
Table 91. Genor BioPharma Co Ltd Revenue in Post Menopausal Osteoporosis Drug Business (2019-2024) & (US$ Million)
Table 92. Genor BioPharma Co Ltd Recent Development
Table 93. InSight Biopharmaceuticals Ltd Company Detail
Table 94. InSight Biopharmaceuticals Ltd Business Overview
Table 95. InSight Biopharmaceuticals Ltd Post Menopausal Osteoporosis Drug Product
Table 96. InSight Biopharmaceuticals Ltd Revenue in Post Menopausal Osteoporosis Drug Business (2019-2024) & (US$ Million)
Table 97. InSight Biopharmaceuticals Ltd Recent Development
Table 98. Eden Biologics Inc Company Detail
Table 99. Eden Biologics Inc Business Overview
Table 100. Eden Biologics Inc Post Menopausal Osteoporosis Drug Product
Table 101. Eden Biologics Inc Revenue in Post Menopausal Osteoporosis Drug Business (2019-2024) & (US$ Million)
Table 102. Eden Biologics Inc Recent Development
Table 103. Enteris BioPharma Inc Company Detail
Table 104. Enteris BioPharma Inc Business Overview
Table 105. Enteris BioPharma Inc Post Menopausal Osteoporosis Drug Product
Table 106. Enteris BioPharma Inc Revenue in Post Menopausal Osteoporosis Drug Business (2019-2024) & (US$ Million)
Table 107. Enteris BioPharma Inc Recent Development
Table 108. Ablynx NV Company Detail
Table 109. Ablynx NV Business Overview
Table 110. Ablynx NV Post Menopausal Osteoporosis Drug Product
Table 111. Ablynx NV Revenue in Post Menopausal Osteoporosis Drug Business (2019-2024) & (US$ Million)
Table 112. Ablynx NV Recent Development
Table 113. Hengenix Biotech Inc Company Detail
Table 114. Hengenix Biotech Inc Business Overview
Table 115. Hengenix Biotech Inc Post Menopausal Osteoporosis Drug Product
Table 116. Hengenix Biotech Inc Revenue in Post Menopausal Osteoporosis Drug Business (2019-2024) & (US$ Million)
Table 117. Hengenix Biotech Inc Recent Development
Table 118. Luye Pharma Group Ltd Company Detail
Table 119. Luye Pharma Group Ltd Business Overview
Table 120. Luye Pharma Group Ltd Post Menopausal Osteoporosis Drug Product
Table 121. Luye Pharma Group Ltd Revenue in Post Menopausal Osteoporosis Drug Business (2019-2024) & (US$ Million)
Table 122. Luye Pharma Group Ltd Recent Development
Table 123. Intas Pharmaceuticals Ltd Company Detail
Table 124. Intas Pharmaceuticals Ltd Business Overview
Table 125. Intas Pharmaceuticals Ltd Post Menopausal Osteoporosis Drug Product
Table 126. Intas Pharmaceuticals Ltd Revenue in Post Menopausal Osteoporosis Drug Business (2019-2024) & (US$ Million)
Table 127. Intas Pharmaceuticals Ltd Recent Development
Table 128. Metabolab Inc Company Detail
Table 129. Metabolab Inc Business Overview
Table 130. Metabolab Inc Post Menopausal Osteoporosis Drug Product
Table 131. Metabolab Inc Revenue in Post Menopausal Osteoporosis Drug Business (2019-2024) & (US$ Million)
Table 132. Metabolab Inc Recent Development
Table 133. Jiangsu Hansoh Pharmaceutical Group Co Ltd Company Detail
Table 134. Jiangsu Hansoh Pharmaceutical Group Co Ltd Business Overview
Table 135. Jiangsu Hansoh Pharmaceutical Group Co Ltd Post Menopausal Osteoporosis Drug Product
Table 136. Jiangsu Hansoh Pharmaceutical Group Co Ltd Revenue in Post Menopausal Osteoporosis Drug Business (2019-2024) & (US$ Million)
Table 137. Jiangsu Hansoh Pharmaceutical Group Co Ltd Recent Development
Table 138. Jiangsu T-mab BioPharma Co Ltd Company Detail
Table 139. Jiangsu T-mab BioPharma Co Ltd Business Overview
Table 140. Jiangsu T-mab BioPharma Co Ltd Post Menopausal Osteoporosis Drug Product
Table 141. Jiangsu T-mab BioPharma Co Ltd Revenue in Post Menopausal Osteoporosis Drug Business (2019-2024) & (US$ Million)
Table 142. Jiangsu T-mab BioPharma Co Ltd Recent Development
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Post Menopausal Osteoporosis Drug Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Post Menopausal Osteoporosis Drug Market Share by Type: 2023 VS 2030
Figure 3. Oral Features
Figure 4. Subcutaneous Features
Figure 5. Intravenous Injection Features
Figure 6. Others Features
Figure 7. Global Post Menopausal Osteoporosis Drug Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Post Menopausal Osteoporosis Drug Market Share by Application: 2023 VS 2030
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Post Menopausal Osteoporosis Drug Report Years Considered
Figure 13. Global Post Menopausal Osteoporosis Drug Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Post Menopausal Osteoporosis Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Post Menopausal Osteoporosis Drug Market Share by Region: 2023 VS 2030
Figure 16. Global Post Menopausal Osteoporosis Drug Market Share by Players in 2023
Figure 17. Global Top Post Menopausal Osteoporosis Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post Menopausal Osteoporosis Drug as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Post Menopausal Osteoporosis Drug Revenue in 2023
Figure 19. North America Post Menopausal Osteoporosis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Post Menopausal Osteoporosis Drug Market Share by Country (2019-2030)
Figure 21. United States Post Menopausal Osteoporosis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Post Menopausal Osteoporosis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Post Menopausal Osteoporosis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Post Menopausal Osteoporosis Drug Market Share by Country (2019-2030)
Figure 25. Germany Post Menopausal Osteoporosis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Post Menopausal Osteoporosis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Post Menopausal Osteoporosis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Post Menopausal Osteoporosis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Post Menopausal Osteoporosis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Post Menopausal Osteoporosis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Post Menopausal Osteoporosis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Post Menopausal Osteoporosis Drug Market Share by Region (2019-2030)
Figure 33. China Post Menopausal Osteoporosis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Post Menopausal Osteoporosis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Post Menopausal Osteoporosis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Post Menopausal Osteoporosis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Post Menopausal Osteoporosis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Post Menopausal Osteoporosis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Post Menopausal Osteoporosis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Post Menopausal Osteoporosis Drug Market Share by Country (2019-2030)
Figure 41. Mexico Post Menopausal Osteoporosis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Post Menopausal Osteoporosis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Post Menopausal Osteoporosis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Post Menopausal Osteoporosis Drug Market Share by Country (2019-2030)
Figure 45. Turkey Post Menopausal Osteoporosis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Post Menopausal Osteoporosis Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Amgen Inc Revenue Growth Rate in Post Menopausal Osteoporosis Drug Business (2019-2024)
Figure 48. Ipsen SA Revenue Growth Rate in Post Menopausal Osteoporosis Drug Business (2019-2024)
Figure 49. Aryogen Pharmed Co Revenue Growth Rate in Post Menopausal Osteoporosis Drug Business (2019-2024)
Figure 50. Lupin Ltd Revenue Growth Rate in Post Menopausal Osteoporosis Drug Business (2019-2024)
Figure 51. Celltrion Inc Revenue Growth Rate in Post Menopausal Osteoporosis Drug Business (2019-2024)
Figure 52. Clayton Biotechnologies Inc Revenue Growth Rate in Post Menopausal Osteoporosis Drug Business (2019-2024)
Figure 53. Hualan Biological Engineering Inc Revenue Growth Rate in Post Menopausal Osteoporosis Drug Business (2019-2024)
Figure 54. Fresenius Kabi SwissBioSim GmbH Revenue Growth Rate in Post Menopausal Osteoporosis Drug Business (2019-2024)
Figure 55. Genor BioPharma Co Ltd Revenue Growth Rate in Post Menopausal Osteoporosis Drug Business (2019-2024)
Figure 56. InSight Biopharmaceuticals Ltd Revenue Growth Rate in Post Menopausal Osteoporosis Drug Business (2019-2024)
Figure 57. Eden Biologics Inc Revenue Growth Rate in Post Menopausal Osteoporosis Drug Business (2019-2024)
Figure 58. Enteris BioPharma Inc Revenue Growth Rate in Post Menopausal Osteoporosis Drug Business (2019-2024)
Figure 59. Ablynx NV Revenue Growth Rate in Post Menopausal Osteoporosis Drug Business (2019-2024)
Figure 60. Hengenix Biotech Inc Revenue Growth Rate in Post Menopausal Osteoporosis Drug Business (2019-2024)
Figure 61. Luye Pharma Group Ltd Revenue Growth Rate in Post Menopausal Osteoporosis Drug Business (2019-2024)
Figure 62. Intas Pharmaceuticals Ltd Revenue Growth Rate in Post Menopausal Osteoporosis Drug Business (2019-2024)
Figure 63. Metabolab Inc Revenue Growth Rate in Post Menopausal Osteoporosis Drug Business (2019-2024)
Figure 64. Jiangsu Hansoh Pharmaceutical Group Co Ltd Revenue Growth Rate in Post Menopausal Osteoporosis Drug Business (2019-2024)
Figure 65. Jiangsu T-mab BioPharma Co Ltd Revenue Growth Rate in Post Menopausal Osteoporosis Drug Business (2019-2024)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
